Introduction
Could a silent condition be putting your liver at risk? Fatty liver disease, a condition characterized by the excessive buildup of fat in the liver, is becoming an increasingly significant health concern worldwide. It affects a substantial portion of the global adult population, with estimates ranging from 30% to 32%. This makes it a leading cause of liver disease globally, and its prevalence is unfortunately on the rise. While a small amount of fat in the liver is normal, when this fat accumulation exceeds 5-10% of the liver's weight, it signifies the presence of fatty liver disease. Often, this condition progresses without noticeable symptoms in its early stages, leading many to be unaware of the potential danger. Understanding what fatty liver disease is, its causes, and how to manage it is crucial for safeguarding your long-term health. There are two primary types of this condition: alcoholic fatty liver disease, which is linked to excessive alcohol consumption, and nonalcoholic fatty liver disease, which occurs in individuals who do not drink heavily.
What Exactly is Fatty Liver Disease?
The liver, a vital organ responsible for numerous bodily functions, including digestion and detoxification, normally contains a small amount of fat. However, when the fat content surpasses 5-10% of the liver's total weight, it is classified as fatty liver disease, also known as steatosis. This seemingly simple accumulation can have significant implications for liver health over time.
Alcoholic Fatty Liver Disease (AFLD) Explained
Alcoholic fatty liver disease (AFLD) is a direct consequence of excessive alcohol intake. When alcohol is consumed, the liver works to break it down for elimination from the body. However, this process can generate harmful substances that damage liver cells, promote inflammation, and impair the liver's natural defenses. The more alcohol a person drinks, the greater the potential for liver damage. AFLD represents the initial stage of alcohol-related liver disease, and even short periods of heavy drinking can lead to fat buildup in the liver. Over time, continued excessive alcohol consumption can progress to more severe forms of liver damage, including alcoholic hepatitis (inflammation of the liver) and cirrhosis (scarring of the liver).
Nonalcoholic Fatty Liver Disease (NAFLD) Explained
Nonalcoholic fatty liver disease (NAFLD), now often referred to as metabolic dysfunction-associated steatotic liver disease (MASLD), describes a condition where there is a buildup of fat in the liver that is not primarily caused by heavy alcohol use. Within NAFLD, there are two main categories: nonalcoholic fatty liver (NAFL), also known as metabolic dysfunction-associated steatotic liver (MASL), where fat is present in the liver with little or no inflammation or liver damage, and nonalcoholic steatohepatitis (NASH), now called metabolic dysfunction-associated steatohepatitis (MASH), which involves fat in the liver along with inflammation and potential liver damage. NASH/MASH is considered a more serious form of NAFLD/MASLD because the inflammation and damage can lead to complications like fibrosis (scarring) and cirrhosis.
How Common is Fatty Liver Disease? (Prevalence Statistics)
The prevalence of fatty liver disease is a significant public health issue. Globally, nonalcoholic fatty liver disease (NAFLD/MASLD) affects approximately 30-32% of adults, and this number is on the rise. Notably, the estimated global prevalence is higher in males (around 40%) compared to females (around 26%). In the United States, NAFLD/MASLD is estimated to affect between 24% and 38% of the adult population, while the more progressive form, NASH/MASH, affects about 1.5% to 6.5% of U.S. adults. Alarmingly, NAFLD/MASLD has become the most common form of liver disease in children in the U.S., with its prevalence more than doubling in the past two decades. This increase in children is likely linked to the rise in childhood obesity. Regional variations in prevalence also exist. In Latin America, the average prevalence of NAFLD/MASLD is around 24% in the general adult population, but this figure can be considerably higher in high-risk groups such as individuals with obesity or type 2 diabetes. For instance, a study conducted in Guayaquil, Ecuador, found that 30% of older adults showed signs of NAFLD. These statistics underscore that fatty liver disease is a widespread condition affecting a significant portion of the population across different demographics and regions.
Why Should You Care? (Significance and Potential Health Risks)
While the early stages of fatty liver disease may not cause immediate health problems, it is crucial to recognize its potential for progression to more severe conditions. Nonalcoholic fatty liver (NAFL/MASL) can advance to nonalcoholic steatohepatitis (NASH/MASH), which involves inflammation and liver damage. Over time, this can lead to fibrosis, a stage where scar tissue forms in the liver. If the scarring continues, it can progress to cirrhosis, a severe and often irreversible condition that impairs liver function. Cirrhosis can ultimately result in liver failure and significantly increases the risk of developing liver cancer. In fact, NAFLD/MASLD is now a leading cause of liver transplantation in the United States, highlighting the severity it can reach. Furthermore, NAFLD/MASLD is not just a liver-specific disease; it is also linked to an increased risk of other serious health problems, including cardiovascular disease, type 2 diabetes, high blood pressure, and kidney disease. This interconnectedness with other metabolic disorders underscores the importance of addressing fatty liver disease for overall well-being.
Unraveling the Causes and Risk Factors
What Leads to Alcoholic Fatty Liver Disease?
The primary culprit behind alcoholic fatty liver disease (AFLD) is heavy and prolonged alcohol consumption. What constitutes "heavy drinking" can vary, but generally, in the UK, it is advised that men and women should not regularly drink more than 14 units of alcohol per week. In the United States, heavy alcohol use is defined as consuming 5 or more drinks on any day or 15 or more per week for men, and 4 or more on any day or 8 or more per week for women. Besides the amount of alcohol consumed, other factors can increase the risk or severity of AFLD. These include being overweight or obese, as individuals with a higher body mass index are more susceptible to liver damage from alcohol. Women also appear to be more vulnerable to the harmful effects of alcohol on the liver compared to men. Having a pre-existing liver condition, such as hepatitis C, can also increase the risk. Genetic factors play a role, with alcohol dependence and problems processing alcohol often running in families. Additionally, cigarette smoking has been associated with a higher risk of alcoholic cirrhosis.
Exploring the Causes and Risk Factors of Nonalcoholic Fatty Liver Disease
The precise cause of nonalcoholic fatty liver disease (NAFLD/MASLD) is not entirely clear, but it is strongly associated with several interconnected factors. Obesity and excess weight are major risk factors, with a high percentage of overweight and obese individuals developing NAFLD/MASLD. Excess fat around the abdomen, often referred to as belly fat, seems to play a particularly significant role. Type 2 diabetes and insulin resistance are also strongly linked to NAFLD/MASLD. In fact, NAFLD/MASLD is more common in people with type 2 diabetes, and conversely, people with NAFLD/MASLD have a higher risk of developing type 2 diabetes. High levels of fats in the blood, particularly high LDL cholesterol and triglycerides, are also established risk factors , and low levels of HDL cholesterol have also been implicated. Genetic predisposition can also influence the likelihood of developing NAFLD/MASLD, with certain gene variations making some individuals more susceptible. For example, variations in the PNPLA3 gene have been identified as a risk factor. Furthermore, NAFLD/MASLD appears to be more prevalent in certain ethnic groups, such as Hispanics, potentially due to genetic and other factors. Lifestyle choices also play a significant role. A diet high in sugar, refined carbohydrates, and saturated fats can contribute to fat buildup in the liver. A lack of physical activity can also increase the risk. Interestingly, rapid weight loss and poor diet can sometimes paradoxically lead to NAFLD/MASLD. Certain medical conditions, such as polycystic ovary syndrome, obstructive sleep apnea, and hypothyroidism, have also been associated with an increased risk of NAFLD/MASLD.
Decoding the Symptoms and Diagnosis
Recognizing the Signs: Common Symptoms
Fatty liver disease, particularly in its early stages, is often referred to as a "silent liver disease" because many individuals experience few or no noticeable symptoms. When symptoms do occur, they tend to be vague and non-specific. Some common symptoms reported include fatigue or extreme tiredness, a general feeling of being unwell (malaise), and discomfort or pain in the upper right side of the abdomen, where the liver is located.
The Silent Threat: When Fatty Liver Disease Shows No Symptoms
Due to the lack of early symptoms, many people live with fatty liver disease without realizing it until it is detected incidentally during medical tests conducted for other reasons. As the disease progresses to more advanced stages, such as nonalcoholic steatohepatitis (NASH/MASH) and cirrhosis, more severe symptoms may begin to appear. These can include jaundice (yellowing of the skin and whites of the eyes), abdominal swelling (ascites), swelling in the legs and ankles (edema), itchy skin, unexplained weight loss, weakness, nausea, and loss of appetite. The appearance of these more pronounced symptoms often indicates that significant liver damage has already occurred.
How is Fatty Liver Disease Diagnosed?
Diagnosing fatty liver disease typically involves a combination of medical history, physical examination, and various tests.
- Blood Tests: Checking Liver Function: Elevated levels of liver enzymes, such as alanine aminotransferase (ALT) and aspartate aminotransferase (AST), detected during routine blood tests can be an initial indication of liver problems, including fatty liver disease. Other blood tests, such as hemoglobin A1c (to check blood sugar control) and a lipid profile (to measure cholesterol and triglycerides), are also often performed. Additionally, doctors may use the results of routine blood tests to calculate special scores, such as the FIB-4 or APRI, which can help identify or rule out advanced liver fibrosis (scarring).
- Imaging Techniques: Seeing Inside Your Liver (Ultrasound, CT Scan, MRI): Non-invasive imaging techniques play a crucial role in diagnosing fatty liver disease. An abdominal ultrasound is often the first imaging test used when liver disease is suspected, as it can effectively detect fat deposits in the liver. Computerized tomography (CT) scans and magnetic resonance imaging (MRI) can also be used to visualize the liver and identify fat accumulation. Newer ultrasound-based techniques like transient elastography (Fibroscan) and magnetic resonance elastography (MRE) can measure the stiffness of the liver, which is a sign of fibrosis or scarring.
- The Importance of Liver Biopsy: A liver biopsy, which involves taking a small sample of liver tissue for examination under a microscope, remains the most accurate method for diagnosing nonalcoholic steatohepatitis (NASH/MASH) and assessing the extent of liver damage and fibrosis. While it is an invasive procedure, it provides valuable information that can help determine the stage and severity of the disease.
Understanding the Stages of Fatty Liver Disease
Fatty liver disease, particularly NAFLD/MASLD, typically progresses through several stages:
- Stage 1: Simple Steatosis – The Initial Fat Buildup: This is the earliest stage, characterized by the accumulation of excess fat in the liver cells. At this stage, there is usually no inflammation or liver damage. Simple steatosis is often reversible with lifestyle modifications.
- Stage 2: Nonalcoholic Steatohepatitis (NASH) / Metabolic dysfunction-associated steatohepatitis (MASH) – Inflammation and Damage: In this stage, the fat buildup is accompanied by inflammation and damage to the liver cells. This inflammation can eventually lead to scarring of the liver tissue.
- Stage 3: Fibrosis – The Onset of Scarring: Persistent inflammation in NASH/MASH can cause scar tissue, known as fibrosis, to form around the liver and nearby blood vessels. While the liver may still be able to function reasonably well at this stage , the presence of scar tissue indicates progressing liver damage.
- Stage 4: Cirrhosis – Severe Scarring and Liver Dysfunction: Cirrhosis represents the most severe stage of fatty liver disease. At this point, the liver has become extensively scarred and damaged, losing its ability to function properly. The damage caused by cirrhosis is often irreversible.
Progression through these stages can take many years, even decades, and the rate of progression varies significantly among individuals. The development of cirrhosis can lead to serious and life-threatening complications, including liver failure and an increased risk of liver cancer (hepatocellular carcinoma).
Table: Stages of Fatty Liver Disease
| Stage | Description | Reversibility | Potential Outcomes |
|---|---|---|---|
| Simple Steatosis | Fat buildup in the liver, usually without inflammation or damage. | Often reversible | May progress to NASH/MASH. |
| NASH/MASH | Fat buildup with inflammation and liver cell damage. | Potentially | May progress to fibrosis. |
| Fibrosis | Scar tissue forms around the liver and blood vessels. | Possible in early stages | May progress to cirrhosis. |
| Cirrhosis | Severe scarring and damage, liver loses its ability to function properly. | Often irreversible | Liver failure, liver cancer, other complications. |
Taking Control: Prevention and Treatment Strategies
Lifestyle Changes: Your First Line of Defense
Adopting a healthy lifestyle is the cornerstone of both preventing and managing fatty liver disease.
- The Power of a Healthy Diet: A balanced diet rich in fruits, vegetables, whole grains, lean protein, and healthy fats is crucial. It is advisable to limit the intake of saturated and trans fats, added sugars, and refined carbohydrates. Drinking plenty of water and unsweetened beverages is also recommended. The Mediterranean diet, which emphasizes plant-based foods and healthy fats, is often suggested for liver health. Interestingly, some studies suggest that consuming coffee may also have benefits for the liver.
- The Benefits of Regular Exercise: Engaging in regular physical activity is highly beneficial for managing fatty liver disease. Aim for at least 150 minutes of moderate-intensity aerobic exercise per week. Exercise can help reduce liver fat, improve insulin resistance, and offer other health advantages, even without significant weight loss. Incorporating both aerobic exercises (like walking or cycling) and resistance exercises (like weight lifting) can be beneficial.
- Achieving and Maintaining a Healthy Weight: Losing even a modest amount of weight, such as 3-10% of your body weight, can significantly improve fatty liver disease. Gradual and sustainable weight loss through a combination of diet and exercise is generally recommended.
- The Importance of Limiting or Avoiding Alcohol: For individuals with alcoholic fatty liver disease, stopping alcohol consumption is the most critical step. Even for those with nonalcoholic fatty liver disease, limiting or avoiding alcohol is advisable as it can potentially worsen the condition.
Medical Treatments and Interventions
While lifestyle changes are the primary approach to managing fatty liver disease, medical interventions may be necessary in some cases.
- Managing Underlying Conditions: It is essential to effectively manage associated health conditions such as type 2 diabetes, high cholesterol, and high blood pressure, as these can contribute to the development and progression of fatty liver disease.
- Current Medications and Emerging Therapies: Currently, there are no specific medications approved for the general treatment of NAFLD/MASLD. However, medications are often used to manage the associated conditions. Notably, resmetirom (Rezdiffra) has recently been approved for adults with NASH/MASH who have moderate to severe liver scarring (fibrosis). This medication helps reduce fat accumulation in the liver. Researchers are also studying other potential treatments, including vitamin E and pioglitazone. Additionally, anti-obesity medications may play a role in managing fatty liver disease.
- When is a Liver Transplant Necessary?: In severe cases where fatty liver disease has progressed to cirrhosis and liver failure, a liver transplant may be the only viable treatment option.
Table: Risk Factors for Nonalcoholic Fatty Liver Disease (NAFLD/MASLD)
| Risk Factor | Explanation/Details |
|---|---|
| Obesity and Excess Weight | Especially excess fat around the waist (belly fat). |
| Type 2 Diabetes | High blood sugar levels and insulin resistance. |
| High Cholesterol and Triglycerides | High levels of LDL cholesterol and triglycerides, low levels of HDL cholesterol. |
| Genetic Predisposition | Certain gene variations (e.g., PNPLA3) may increase risk. |
| Older Age | Risk increases with age (especially for NASH/MASH). |
| Certain Ethnicities | Higher prevalence in Hispanic and Asian populations. |
| Metabolic Syndrome | Combination of high blood pressure, high blood sugar, unhealthy cholesterol levels, and abdominal obesity. |
| Polycystic Ovary Syndrome (PCOS) | Hormonal imbalance in women. |
| Sleep Apnea | Breathing disorder during sleep. |
| Hypothyroidism | Underactive thyroid gland. |
| Certain Medications | Some drugs can increase the risk of NAFLD. |
| Rapid Weight Loss and Poor Diet | Can sometimes lead to NAFLD. |
Table: Diagnostic Methods for Fatty Liver Disease
| Diagnostic Method | How it Works | What it Detects |
|---|---|---|
| Blood Tests | Check levels of liver enzymes (ALT, AST), blood sugar, cholesterol, triglycerides. | Liver inflammation, liver function, associated metabolic conditions. |
| Abdominal Ultrasound | Uses sound waves to create images of the liver. | Fat deposits in the liver. |
| CT Scan | Uses X-rays and computer technology to create detailed images of the liver. | Fat deposits, can show signs of advanced liver disease. |
| MRI | Uses radio waves and magnets to create detailed images of the liver. | Fat deposits, can show signs of advanced liver disease. |
| Transient Elastography | A special type of ultrasound that measures liver stiffness. | Liver fibrosis (scarring). |
| Magnetic Resonance Elastography | Combines MRI with sound waves to create a visual map of liver stiffness. | Liver fibrosis (scarring). |
| Liver Biopsy | Removal of a small tissue sample from the liver for examination under a microscope. | Presence and severity of fat, inflammation, liver damage, and fibrosis. |
Conclusion
Fatty liver disease is a prevalent condition that often progresses silently, yet it carries the potential for serious health consequences. Understanding the distinction between alcoholic and nonalcoholic forms, recognizing the risk factors, and being aware of the diagnostic methods are the first steps in protecting your liver health. Early detection, primarily through awareness of risk factors and routine medical checkups, is crucial because the initial stages of fatty liver disease are often reversible with lifestyle modifications. The power to prevent or manage this condition largely lies in adopting and maintaining healthier habits. A balanced diet, regular physical activity, achieving and maintaining a healthy weight, and limiting or avoiding alcohol consumption can significantly impact your liver health. While medical treatments are evolving, with the recent approval of resmetirom offering a targeted therapy for NASH/MASH, lifestyle changes remain the cornerstone of management. If you have risk factors for fatty liver disease, such as obesity, type 2 diabetes, high cholesterol, or a history of heavy alcohol use, or if you are experiencing any of the symptoms, it is essential to consult with a healthcare provider. Taking proactive steps today can lead to a healthier liver and a better overall quality of life for years to come.
Works cited
- pmc.ncbi.nlm.nih.gov, accessed April 4, 2025, https://pmc.ncbi.nlm.nih.gov/articles/PMC10029957/#:~:text=Nonalcoholic%20fatty%20liver%20disease%20(NAFLD,compared%20to%20females%20(26%25).
- The global epidemiology of nonalcoholic fatty liver disease (NAFLD) and nonalcoholic steatohepatitis (NASH): a systematic review - NATAP, accessed April 4, 2025, https://www.natap.org/2024/HCV/the_global_epidemiology_of_nonalcoholic_fatty.27.pdf
- Global incidence and prevalence of nonalcoholic fatty liver disease - Clinical and Molecular Hepatology, accessed April 4, 2025, http://e-cmh.org/upload/pdf/cmh-2022-0365.pdf
- Up-to-date global epidemiology of nonalcoholic fatty liver disease - Manikat, accessed April 4, 2025, https://hbsn.amegroups.org/article/view/118927/html
- Global incidence and prevalence of nonalcoholic fatty liver disease - PMC, accessed April 4, 2025, https://pmc.ncbi.nlm.nih.gov/articles/PMC10029957/
- The global epidemiology of nonalcoholic fatty liver disease (NAFLD) and nonalcoholic steatohepatitis (NASH): a systematic review - PMC, accessed April 4, 2025, https://pmc.ncbi.nlm.nih.gov/articles/PMC10026948/
- Nonalcoholic Fatty Liver Disease (NAFLD) - American Liver Foundation, accessed April 4, 2025, https://liverfoundation.org/liver-diseases/fatty-liver-disease/nonalcoholic-fatty-liver-disease-nafld/
- Definition of fatty liver disease - NCI Dictionary of Cancer Terms, accessed April 4, 2025, https://www.cancer.gov/publications/dictionaries/cancer-terms/def/fatty-liver-disease
- Fatty Liver Disease | MedlinePlus, accessed April 4, 2025, https://medlineplus.gov/fattyliverdisease.html
- Alcohol-related liver disease - NHS, accessed April 4, 2025, https://www.nhs.uk/conditions/alcohol-related-liver-disease-arld/
- Alcohol-Associated Liver Disease | Johns Hopkins Medicine, accessed April 4, 2025, https://www.hopkinsmedicine.org/health/conditions-and-diseases/alcoholinduced-liver-disease
- Steatotic (Fatty) Liver Disease: Symptoms & Treatment - Cleveland Clinic, accessed April 4, 2025, https://my.clevelandclinic.org/health/diseases/15831-fatty-liver-disease
- Alcoholic liver disease: Symptoms, treatment, and causes - Medical News Today, accessed April 4, 2025, https://www.medicalnewstoday.com/articles/215638
- Alcohol-related Liver Disease - Yale Medicine, accessed April 4, 2025, https://www.yalemedicine.org/conditions/alcohol-related-liver-disease
- Definition & Facts of NAFLD & NASH - NIDDK, accessed April 4, 2025, https://www.niddk.nih.gov/health-information/liver-disease/nafld-nash/definition-facts
- Nonalcoholic Fatty Liver Disease (NAFLD) & NASH - NIDDK, accessed April 4, 2025, https://www.niddk.nih.gov/health-information/liver-disease/nafld-nash
- Nonalcoholic fatty liver disease: MedlinePlus Medical Encyclopedia, accessed April 4, 2025, https://medlineplus.gov/ency/article/007657.htm
- Nonalcoholic fatty liver disease - Symptoms and causes - Mayo Clinic, accessed April 4, 2025, https://www.mayoclinic.org/diseases-conditions/nonalcoholic-fatty-liver-disease/symptoms-causes/syc-20354567
- Nonalcoholic Fatty Liver Disease - Johns Hopkins Medicine, accessed April 4, 2025, https://www.hopkinsmedicine.org/health/conditions-and-diseases/nonalcoholic-fatty-liver-disease
- Non-Alcoholic Fatty Liver Disease - Symptoms and Causes - Penn Medicine, accessed April 4, 2025, https://www.pennmedicine.org/for-patients-and-visitors/patient-information/conditions-treated-a-to-z/non-alcoholic-fatty-liver-disease
- NASH Overview: Causes, Symptoms, Diagnosis, and Treatment | Pfizer, accessed April 4, 2025, https://www.pfizer.com/disease-and-conditions/nash
- Understanding the Burden of Nonalcoholic Fatty Liver Disease: Time for Action, accessed April 4, 2025, https://diabetesjournals.org/spectrum/article/37/1/9/153831/Understanding-the-Burden-of-Nonalcoholic-Fatty
- Fatty Liver Disease - American Liver Foundation, accessed April 4, 2025, https://liverfoundation.org/about-your-liver/facts-about-liver-disease/fatty-liver-disease/
- The global epidemiology of nonalcoholic fatty liver disease (NAFLD) and nonalcoholic steatohepatitis (NASH): a systematic review - PubMed, accessed April 4, 2025, https://pubmed.ncbi.nlm.nih.gov/36626630/
- Non-alcoholic fatty liver disease prevalence in Latin America: A systematic review and meta-analysis | Annals of Hepatology - Elsevier, accessed April 4, 2025, https://www.elsevier.es/en-revista-annals-hepatology-16-articulo-non-alcoholic-fatty-liver-disease-prevalence-S1665268122000485
- Nonalcoholic Fatty Liver Disease Risk Factors in Latin American Populations: Current Scenario and Perspectives - PubMed Central, accessed April 4, 2025, https://pmc.ncbi.nlm.nih.gov/articles/PMC6465959/
- Non-alcoholic Fatty Liver Disease prevalence in Latin America: A systematic review and meta-analysis | Request PDF - ResearchGate, accessed April 4, 2025, https://www.researchgate.net/publication/360014567_Non-alcoholic_Fatty_Liver_Disease_prevalence_in_Latin_America_A_systematic_review_and_meta-analysis
- (PDF) Waist Circumference as a Risk Factor for Non-Alcoholic Fatty Liver Disease in Older Adults in Guayaquil, Ecuador - ResearchGate, accessed April 4, 2025, https://www.researchgate.net/publication/370024246_Waist_Circumference_as_a_Risk_Factor_for_Non-Alcoholic_Fatty_Liver_Disease_in_Older_Adults_in_Guayaquil_Ecuador
- Waist Circumference as a Risk Factor for Non-Alcoholic Fatty Liver Disease in Older Adults in Guayaquil, Ecuador - MDPI, accessed April 4, 2025, https://www.mdpi.com/2308-3417/8/2/42
- Non-alcoholic fatty liver disease (NAFLD) - NHS, accessed April 4, 2025, https://www.nhs.uk/conditions/non-alcoholic-fatty-liver-disease/
- Nonalcoholic Fatty Liver - StatPearls - NCBI Bookshelf, accessed April 4, 2025, https://www.ncbi.nlm.nih.gov/books/NBK541033/
- Fatty Liver Stages - Types, Symptoms, Causes, Treatment Options - Narayana Health, accessed April 4, 2025, https://www.narayanahealth.org/blog/fatty-liver-stages-types-symptoms-causes-treatment-options
- Fatty Liver-to-Cirrhosis Timeline: Progression and Prevention Strategies, accessed April 4, 2025, https://www.webmd.com/fatty-liver-disease/fatty-liver-to-cirrhosis-timeline
- Liver Disease: Signs & Symptoms, Causes, Stages, Treatment - Cleveland Clinic, accessed April 4, 2025, https://my.clevelandclinic.org/health/diseases/17179-liver-disease
- How long does it take for fatty liver to turn into cirrhosis? - Medical News Today, accessed April 4, 2025, https://www.medicalnewstoday.com/articles/fatty-liver-to-cirrhosis-timeline
- Liver - fatty liver disease | Better Health Channel, accessed April 4, 2025, https://www.betterhealth.vic.gov.au/health/conditionsandtreatments/liver-fatty-liver-disease
- Fatty liver disease diet: foods to prevent and reverse fatty liver - UChicago Medicine, accessed April 4, 2025, https://www.uchicagomedicine.org/forefront/gastrointestinal-articles/fatty-liver-disease-diet
- Fatty Liver Disease - Obesity & Metabolic Health, accessed April 4, 2025, https://www.uclahealth.org/medical-services/comet/fatty-liver-disease
- Fatty liver — symptoms, causes and treatment | healthdirect, accessed April 4, 2025, https://www.healthdirect.gov.au/fatty-liver
- Alcohol-related liver disease - Causes - NHS, accessed April 4, 2025, https://www.nhs.uk/conditions/alcohol-related-liver-disease-arld/causes/
- Alcoholic Liver Disease: Pathogenesis and Current Management - PMC - PubMed Central, accessed April 4, 2025, https://pmc.ncbi.nlm.nih.gov/articles/PMC5513682/
- www.hopkinsmedicine.org, accessed April 4, 2025, https://www.hopkinsmedicine.org/health/conditions-and-diseases/nonalcoholic-fatty-liver-disease#:~:text=Metabolic%20dysfunction%2Dassociated%20steatotic%20liver%20disease%20(MASLD)%20is%20when,common%20cause%20of%20this%20disease.
- MASLD, NAFLD and fatty liver disease - British Liver Trust, accessed April 4, 2025, https://britishlivertrust.org.uk/information-and-support/liver-conditions/masld-nafld-and-fatty-liver-disease/
- Nonalcoholic fatty liver disease - Diagnosis and treatment - Mayo Clinic, accessed April 4, 2025, https://www.mayoclinic.org/diseases-conditions/nonalcoholic-fatty-liver-disease/diagnosis-treatment/drc-20354573
- Diagnosis of NAFLD & NASH - NIDDK, accessed April 4, 2025, https://www.niddk.nih.gov/health-information/liver-disease/nafld-nash/diagnosis
- Metabolic Dysfunction–Associated Steatotic Liver Disease | Conditions - UCSF Health, accessed April 4, 2025, https://www.ucsfhealth.org/conditions/metabolic-dysfunction-associated-steatotic-liver-disease
- The four stages of Non-Alcoholic Fatty Liver Disease (NAFLD) - liver-health-uk, accessed April 4, 2025, https://www.liverhealthuk.com/post/the-four-stages-of-nafld
- How Long Does It Take for Fatty Liver Disease to Progress to Cirrhosis? - Healthline, accessed April 4, 2025, https://www.healthline.com/health/fatty-liver-to-cirrhosis-timeline
- www.mayoclinic.org, accessed April 4, 2025, https://www.mayoclinic.org/diseases-conditions/nonalcoholic-fatty-liver-disease/symptoms-causes/syc-20354567#:~:text=Drinking%20alcohol%20can%20damage%20your,a%20healthy%20diet%20and%20exercising.
- Non-Alcoholic Fatty Liver Disease, accessed April 4, 2025, https://www.bcm.edu/sites/default/files/a-guide-to-what-and-how-to-eat-non-alcoholic-fatty-liver-disease.pdf
- Diet For Fatty Liver Repair: Foods Good For Liver Health | Hepatitis NSW, accessed April 4, 2025, https://www.hep.org.au/liver-health/diet-liver-health/
- Fatty Liver Diet: What Foods to Eat and What Foods to Avoid - Healthline, accessed April 4, 2025, https://www.healthline.com/health/fatty-liver-diet
- Liver Disease Diets: Fatty Liver Diet and More - American Liver Foundation, accessed April 4, 2025, https://liverfoundation.org/health-and-wellness/healthy-lifestyle/liver-disease-diets/
- Exercise for fatty liver disease has benefits beyond weight loss - Liver Foundation, accessed April 4, 2025, https://liver.org.au/news/exercise-for-fatty-liver-disease-has-benefits-beyond-weight-loss/
- Physical Activity Protocols in Non-Alcoholic Fatty Liver Disease Management: A Systematic Review of Randomized Clinical Trials and Animal Models - PubMed Central, accessed April 4, 2025, https://pmc.ncbi.nlm.nih.gov/articles/PMC10379178/
- Exercise in the Management of Metabolic-Associated Fatty Liver Disease (MAFLD) in Adults: A Position Statement from Exercise and Sport Science Australia - PubMed Central, accessed April 4, 2025, https://pmc.ncbi.nlm.nih.gov/articles/PMC10687186/
- Exercise Advice for patients with fatty liver disease (MAFLD), accessed April 4, 2025, http://www.liverwellnessprogram.com/exercise-advice-for-patients-with-fatty-liver-disease-mafld.html
- Diet and Lifestyle Tips to Reverse Fatty Liver Disease - WebMD, accessed April 4, 2025, https://www.webmd.com/fatty-liver-disease/fatty-liver-disease-diet
- Treatment for NAFLD & NASH - NIDDK, accessed April 4, 2025, https://www.niddk.nih.gov/health-information/liver-disease/nafld-nash/treatment
- What is the best medication for fatty liver disease?, accessed April 4, 2025, https://www.medicalnewstoday.com/articles/best-medication-for-fatty-liver
- www.mayoclinic.org, accessed April 4, 2025, https://www.mayoclinic.org/diseases-conditions/nonalcoholic-fatty-liver-disease/diagnosis-treatment/drc-20354573#:~:text=Weight%2Dloss%20surgery%20or%20medicines,recommended%20for%20people%20with%20cirrhosis.
- FDA Approves Rezdiffra, the First Drug for NASH, a Form of Fatty Liver Disease > News > Yale Medicine, accessed April 4, 2025, https://www.yalemedicine.org/news/rezdiffra-for-nash-nonalcoholic-steatohepatitis
